Jonathan P. Galeotti

发表

A giant soft tissue lesion of the male perineum: Unusual presentation of a cellular angiofibroma

D. Cardona, D. Blazer, B. Ezekian, 2017 .

The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanoma

M. Gulley, Douglas B. Johnson, R. Alkallas, 2022, BMC Cancer.

Genomic characteristics and prognostic significance of co‐mutated ASXL1/SRSF2 acute myeloid leukemia

Steven M. Johnson, Daniel R. Richardson, O. Chan, 2021, American journal of hematology.

Inhibition of Glycogen Synthase Kinase 3&bgr; During Heart Failure Is Protective

J. Ávila, J. Sadoshima, C. Hong, 2007, Circulation research.

Inhibition of Glycogen Synthase Kinase 3 (cid:1) During Heart Failure Is Protective Integrative Physiology

J. Ávila, J. Sadoshima, C. Hong, 2007 .

Venetoclax‐induced tumour lysis syndrome in acute myeloid leukaemia

Daniel R. Richardson, Nathan D. Montgomery, J. Zeidner, 2020, British journal of haematology.

Identification of high-risk monomorphic post-transplant lymphoproliferative disorder following solid organ transplantation

Nathan D. Montgomery, A. Beaven, C. Dittus, 2020, Leukemia & lymphoma.

Clonal evolution of Philadelphia chromosome in acute myeloid leukemia after enasidenib treatment

Daniel R. Richardson, L. Ramkissoon, K. Kaiser-Rogers, 2021, Leukemia & lymphoma.

Bilineal evolution of a U2AF1-mutated clone associated with acquisition of distinct secondary mutations

Steven M. Johnson, E. Weimer, Nathan D. Montgomery, 2021, Blood advances.

An Angiotensin II Type 1 Receptor Mutant Lacking Epidermal Growth Factor Receptor Transactivation Does Not Induce Angiotensin II–Mediated Cardiac Hypertrophy

J. Sadoshima, T. Wagner, P. Zhai, 2006, Circulation research.

Cardiac-specific overexpression of AT1 receptor mutant lacking Gαq/Gαi coupling causes hypertrophy and bradycardia in transgenic mice

D. Roden, S. Vatner, T. Wagner, 2005 .

Endocytosis machinery is required for beta1-adrenergic receptor-induced hypertrophy in neonatal rat cardiac myocytes.

S. Vatner, D. Vatner, J. Sadoshima, 2008, Cardiovascular research.

A retrospective study on prephase therapy prior to definitive multiagent chemotherapy in aggressive lymphomas

H. Muss, A. Beaven, C. Dittus, 2018, Leukemia & lymphoma.

Epstein-Barr virus-negative diffuse large B cell lymphoma with aberrant expression of CD3 and other T cell-associated antigens: report of three cases with a review of the literature

C. Rehder, Endi Wang, S. Sebastian, 2016, Annals of Hematology.

Differential Roles of GSK-3&bgr; During Myocardial Ischemia and Ischemia/Reperfusion

M. Volpe, J. Sadoshima, P. Zhai, 2011, Circulation research.

Constitutively active MEK1 rescues cardiac dysfunction caused by overexpressed GSK-3α during aging and hemodynamic pressure overload.

Y. Maejima, J. Sadoshima, J. Molkentin, 2012, American journal of physiology. Heart and circulatory physiology.

Persistent thrombocytopaenia in a young man with splenomegaly, rebound thrombocytosis after splenectomy and subsequent pulmonary embolism: splenic littoral cell angioma and associated events

Gustaaf G. de Ridder, J. Carney, Endi Wang, 2015, BMJ Case Reports.

Metastatic Gallbladder Cancer Masquerading as Primary Colon Malignancy

S. McCall, C. Mantyh, Zhifei Sun, 2015 .

Unconventional Signalling Mechanisms Mediated by the Angiotensin II Type 1 Receptor in Cardiovascular Cell Types

J. Sadoshima, P. Zhai, Jonathan P. Galeotti, 2006 .

Cardiac-specific overexpression of AT1 receptor mutant lacking G alpha q/G alpha i coupling causes hypertrophy and bradycardia in transgenic mice.

D. Roden, S. Vatner, D. Vatner, 2005, The Journal of clinical investigation.

A reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid disease

Steven M. Johnson, Daniel R. Richardson, L. Ramkissoon, 2023, Blood cancer journal.

Acute Myeloid Leukemia with Co-mutated ASXL1 and SRSF2 Exhibits Monocytic Differentiation and has a Mutational Profile Overlapping with Chronic Myelomonocytic Leukemia

Anqi Zhu, Steven M. Johnson, Daniel R. Richardson, 2019, HemaSphere.

Clinical and molecular features of FLT3 juxtamembrane domain missense mutations in acute myeloid leukaemia

Nathan D. Montgomery, J. Zeidner, M. Foster, 2022, Journal of cellular and molecular medicine.

ASXL1/SRSF2 Co-Mutated Acute Myeloid Leukemia (AML): A Rare but Distinct Subpopulation with Dismal Outcomes

A. Ivanova, Steven M. Johnson, Daniel R. Richardson, 2019, Blood.

Multiple lineage switches in KMT2A rearranged infant leukemia, responsive to combination therapy with CPX-351 and inotuzumab.

J. Sperlazza, Thomas B. Alexander, Jonathan P. Galeotti, 2023, Pediatric Blood & Cancer.

Myeloid sarcoma manifesting as generalized lymphadenopathy in a patient with myelofibrosis

Nathan D. Montgomery, J. Zeidner, C. Coombs, 2019, Clinical case reports.

Comprehensive Genomic Characterization of ASXL1 C.1934dupG (p.G646fs*12) Versus Other ASXL1 mutations in Myeloid Neoplasia

S. Ramkissoon, Steven M. Johnson, Daniel R. Richardson, 2021, Blood.

Differential Roles of GSK-3&bgr; During Myocardial Ischemia and Ischemia/Reperfusion

M. Volpe, J. Sadoshima, P. Zhai, 2011, Circulation research.

Inhibition of Glycogen Synthase Kinase 3 (cid:1) During Heart Failure Is Protective Integrative Physiology

J. Sadoshima, C. Hong, P. Zhai, 2007 .

Inhibition of Glycogen Synthase Kinase 3 (cid:1) During Heart Failure Is Protective Integrative Physiology

J. Sadoshima, C. Hong, P. Zhai, 2007 .

Inhibition of Glycogen Synthase Kinase 3 (cid:1) During Heart Failure Is Protective Integrative Physiology

J. Ávila, J. Sadoshima, C. Hong, 2007 .